Usana Health Sciences (USNA) FCF Margin (2011 - 2026)

Usana Health Sciences (USNA) has reported FCF Margin for 16 consecutive years, with 9.03% the latest figure, recorded in Q3 2026.

• On a quarterly basis, FCF Margin rose 598.0% year-over-year to 9.03% in Q3 2026; TTM through Jul 2026 was 1.74%, a 393.0% decrease from a year earlier, with the FY2026 full-year figure at 0.92%, down 504.0% from the prior year.
• FCF Margin was 9.03% for Q3 2026 at Usana Health Sciences, up from 2.84% in the prior quarter.
• Over five years, FCF Margin peaked at 16.31% in Q4 2022 and troughed at 2.73% in Q1 2026.
• A 5-year average of 5.56% and a median of 4.32% in 2023 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin surged 1366 bps in 2022 and sank 1597 bps in 2025, its largest moves.
• Over 5 years, FCF Margin stood at 16.31% in 2022, then slumped by 48 bps to 8.46% in 2023, then tumbled by 78 bps to 1.86% in 2024, then sank by 229 bps to 2.41% in 2025, then jumped by 474 bps to 9.03% in 2026.
• The last three FCF Margin figures came in at 9.03% (Q3 2026), 2.84% (Q2 2026), and 2.73% (Q1 2026), per Business Quant data.